| Application no. and date | 00928046.2 (espacenet) (Federated) (European Patent Register), 20000419 | | Patent/reg. no. and date | DK/EP 1173205, 20050601 | | Publication date | 20020123 | | Priority no. and date | SE 9901387, 19990419 | | EP pub. no. and date |
EP 1173205 20020123 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | ABRAHAMSSON, Bertil, AstraZeneca R & D Mölndal
S-431 83 Mölndal, SE,
UNGELL, Anna-Lena, AstraZeneca R & D Mölndal
S-431 83 Mölndal, SE,
LINDQVIST, Ann-Margret, AstraZeneca R & D Molndal
S-431 83 Molndal, SE | | Representative | | | Opponent | | | IPC Class | A61K 45/00 (2006.01) , A61K 9/20 (2006.01) , A61P 3/06 (2006.01) | | Title | Oral formulering til ileum-indgivelse, omfattende en forbindelse til inhibering af ileum-galdesyretransporten | | Int. application no. | SE2000000755 | | Int. publication no. | WO2000062810 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
